Filing Details
- Accession Number:
- 0000891293-22-000033
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-17 16:57:44
- Reporting Period:
- 2022-06-17
- Accepted Time:
- 2022-06-17 16:57:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891293 | Cti Biopharma Corp | CTIC | Pharmaceutical Preparations (2834) | 911533912 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1276750 | David Kirske | Cti Biopharma Corp. 3101 Western Ave., Suite 800 Seattle WA 98121 | Evp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-17 | 10,000 | $1.00 | 17,397 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-06-17 | 10,000 | $6.00 | 7,397 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-06-17 | 50,000 | $3.30 | 57,397 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-06-17 | 50,000 | $6.25 | 7,397 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-06-17 | 10,000 | $0.00 | 10,000 | $1.00 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-06-17 | 50,000 | $0.00 | 50,000 | $3.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 340,000 | 2030-03-11 | No | 4 | M | Direct | |
| 150,000 | 2031-03-10 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a 10b5-1 sales plan adopted by the reporting person.
- One sixth of the shares underlying the option vested on 9/11/2020 and semi-annually thereafter until all the underlying shares will be fully vested on 3/11/2023.
- One sixth of the shares underlying the option vested on 9/10/2021 and semi-annually thereafter until all the underlying shares will be fully vested on 3/10/2024.
Billionaire Hedge Funds
